NAOV Logo

NanoVibronix, Inc. (NAOV) 

NASDAQ
Market Cap
$1.7M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
645 of 790
Rank in Industry
82 of 102

Largest Insider Buys in Sector

NAOV Stock Price History Chart

NAOV Stock Performance

About NanoVibronix, Inc.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and …

Insider Activity of NanoVibronix, Inc.

Over the last 12 months, insiders at NanoVibronix, Inc. have bought $0 and sold $0 worth of NanoVibronix, Inc. stock.

On average, over the past 5 years, insiders at NanoVibronix, Inc. have bought $32,630 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 50,000 shares for transaction amount of $12,500 was made by MIKA THOMAS (director) on 2023‑01‑05.

List of Insider Buy and Sell Transactions, NanoVibronix, Inc.

2023-01-05Purchasedirector
50,000
0.1669%
$0.25$12,500-38.64%
2022-06-15Purchase
40,000
0.1447%
$0.60$23,828-43.37%
2022-06-14PurchaseChief Financial Officer
4,000
0.0143%
$0.57$2,296-41.64%
2022-06-01Purchase
2,000
0.0071%
$0.69$1,380-49.71%
2020-09-29Purchasedirector
10,000
0.1144%
$0.79$7,887+33.47%
2019-11-20Purchasedirector
25,000
0.2453%
$2.00$50,000-27.05%

Insider Historical Profitability

<0.0001%
FASHEK CHRISTOPHER M
75000
2.6936%
$0.6130<0.0001%
MIKA THOMASdirector
50000
1.7958%
$0.6110<0.0001%
BROWN STEPHEN RUSSELLChief Financial Officer
4000
0.1437%
$0.6110<0.0001%
Cassirer Aurora
2000
0.0718%
$0.6110<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.